Clincosm LogoSign in Get a demo

light chain (al) amyloidosis

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Light Chain (AL) Amyloidosis Trial in Worldwide (Birtamimab, Placebo, Standard of Care Chemotherapy)

Recruiting
  • Light Chain (AL) Amyloidosis
  • Hartford, Connecticut
  • +120 more
Aug 8, 2022

Light Chain (AL) Amyloidosis, Cardiac Involvement Trial in Heidelberg (Epigallocatechin-3-gallate (EGCG), Placebo)

Completed
  • Light Chain (AL) Amyloidosis
  • Cardiac Involvement
  • Epigallocatechin-3-gallate (EGCG)
  • Placebo
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital of Heidelberg; Medical Department V
Oct 16, 2017